Share this article
During the Expo China International Import Expo, the Norwegian delegation of Aker Biomarine will bear witness to the signing with a total of 18 strategic partners from the human health & nutrition and pet food industries.
“China is the world’s second-largest importer and consumer in the world. It is a key strategic market for Aker BioMarine. We have solidified many long-term partnerships in the country. The upcoming Expo is a great opportunity for us to officially declare our collaborations and progress in the Chinese market,” said Thong Luu, SVP of Human Health & Nutrition Asia, Aker BioMarine.
Company representatives will talk to attendees about how krill is a superior source of omega-3. Besides, a choline for the human nutrition supplement market. Also, it will offer product samples from its stand, as well as run live streaming and sales offers.
Moreover, Regional Sales Director, HH&N China, Jim Wang explained: “CIIE is attended by hundreds of industry leaders and large organizations from around the world. It’s a key event for us to promote our products to current and potential customers, officials, and consumers. We are excited to take part and share the benefits of krill. As well as celebrate and solidify our many partnerships in China.”
5th Annual CIIE held at the National Convention and Exhibition Center
CIIE, officially launched in 2018, is an initiative from Chinese President Xi Jinping to support economic globalization in the country.
The Expo is hosted by the Ministry of Commerce of the People’s Republic of China and the Shanghai Municipal People’s Government. It will take place at the National Convention and Exhibition Center in Shanghai.
About Aker BioMarine ASA
Aker BioMarine ASA is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba Krill®), aquaculture (QRILL® Aqua), and animal feed applications (QRILL® Pet), including INVI™, a highly concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill.
In addition, the company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world.
Finally, its strong focus on sustainability inspired the launch of AION by Aker BioMarine. A circularity company dedicated to helping companies to recycle and reuse waste.
Some days ago, Aker BioMarine reported a 23% increase in its krill production in the first nine months of 2022 compared to the same period last year. You can read an exclusive talk with between CEO Matts Johansen and WeAreAquaculture here.
Share this article